In the human fungal biodata, Malassezia is the dominant species. It is a skin commensal that has been implicated in diseases such as pityriasis versicolor (PV), Malassezia folliculitis (MF), seborrhoeic dermatitis, atopic dermatitis and psoriasis.
(1) Environmental factors such as increased temperature, sweating, seborrhoea, (2) and immunosuppressive conditions such as human immunodeficiency virus (HIV) infections, diabetes mellitus and corticosteroid use predispose to the development of PV and MF.
A 24-year-old Chinese man was referred to the dermatology clinic for an asymptomatic rash on his back, arms, thighs and buttocks of two months' duration. The patient had a past medical history of Evan's syndrome (autoimmune thrombocytopenia and haemolytic anaemia), for which he was on long-term azathioprine and prednisolone for immunosuppression. He was otherwise well and had no constitutional symptoms. On examination of the affected areas, there was a monomorphic erythematous pustular eruption with multiple annular scaly hypopigmented macules and patches within ( Fig. 1) . A fungal scrape from lesional areas was positive for hyphae and spores. was given a further two-week course of oral ketoconazole. At that time, the haematologist also added cyclophosphamide to his immunosuppressive regime. After a total of five weeks of oral antifungals, his rash still failed to resolve. He was then prescribed itraconazole 200 mg OM for one week, followed by 100 mg OM for three weeks, which resulted in successful eradication of disease.
The various manifestations of Malassezia infections differ based on pathophysiology.
For PV, lipase produced by Malassezia metabolises various fatty acids, producing metabolites (such as azelaic acid) that block the passage of tyrosine to melanin, resulting in hypopigmented macules. (2) The predominant species is M. globosa. (4) Microscopy shows the typical 'spaghetti and meatballs' appearance of both hyphae and spores, and this dimorphic appearance is unique to PV. (5) There is an absence of an inflammatory infiltrate in histopathology. 
The azole drugs, such as ketoconazole, itraconazole and voriconazole, have high in vitro antifungal efficacy in Malassezia species and are good options for systemic management of Malassezia infections, (8) although a prolonged course may be necessary for clinical resolution, as illustrated in this case.
The presentation of both PV and MF in the same patient and at the same location highlights that two different pathological processes can occur simultaneously. The use of augmented immunosuppressive therapy may have predisposed the patient to dual manifestations of Malassezia infections. 
